---
title: "Viking Therap (VKTX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VKTX.US/norm.md"
symbol: "VKTX.US"
name: "Viking Therap"
parent: "https://longbridge.com/en/quote/VKTX.US.md"
datetime: "2026-05-20T15:31:34.563Z"
locales:
  - [en](https://longbridge.com/en/quote/VKTX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VKTX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VKTX.US/norm.md)
---

# Viking Therap (VKTX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -1.37 | -1.38 | -0.8083 | -0.5847 | -0.4072 |
| ROE | -111.01% | -93.28% | -48.15% | -31.93% | -21.13% |
| Revenue | - | - | - | - | - |
| Net income | -158.32M | -157.66M | -90.79M | -65.56M | -45.63M |
| Operating income | -164.13M | -164.74M | -98.56M | -74.57M | -55.47M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 608.24M | 715.73M | 739.41M | 827.85M | 866.99M |
| Leverage | 1.21 | 1.12 | 1.04 | 1.04 | 1.02 |
| BVPS | 4.33 | 5.57 | 6.34 | 7.08 | 7.54 |
| Turnover | - | - | - | - | - |
| Cash & STI | 602.96M | 705.74M | 714.57M | 807.72M | 851.86M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | 85000.00 | 666000.00 | 780000.00 | 892000.00 |
| Net debt | -602.96M | -705.60M | -713.82M | -806.85M | -850.86M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -113.98M | -85.29M | -94.00M | -47.06M | -52.33M |
| Investing CF | 54.19M | 75.61M | 160.03M | 42.51M | 63.24M |
| Financing CF | 12.08M | 75.10M | 480000.00 | 507000.00 | 349000.00 |
| Free CF | -57.75M | -29.11M | -64.87M | -25.64M | -40.62M |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |